Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15454217rdf:typepubmed:Citationlld:pubmed
pubmed-article:15454217lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:15454217lifeskim:mentionsumls-concept:C1261322lld:lifeskim
pubmed-article:15454217lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:15454217lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:15454217lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:15454217lifeskim:mentionsumls-concept:C0756977lld:lifeskim
pubmed-article:15454217lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15454217lifeskim:mentionsumls-concept:C1710236lld:lifeskim
pubmed-article:15454217lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:15454217pubmed:issue21lld:pubmed
pubmed-article:15454217pubmed:dateCreated2004-9-29lld:pubmed
pubmed-article:15454217pubmed:abstractTextDeoxyxylulose 5-phosphate (DXP) analogs were synthesized and evaluated as alternative substrates and inhibitors of recombinant Synechocystis PCC6803 DXP reductoisomerase (DXR; EC 1.1.1.267). Five of the compounds tested (1,2-dideoxy-D-threo-3-hexulose 6-phosphate, 1-deoxy-l-ribulose 5-phosphate, 2S,3R-dihydroxybutyramide 4-phosphate, 4S-hydroxypentan-2-one 5-phosphate, and 3S-hydroxypentan-2-one 5-phosphate) acted as relatively weak competitive inhibitors when compared to fosmidomycin. A sixth compound, 3R,4S-dihydroxy-5-oxohexylphosphonic acid, served as an alternate substrate, as has recently been reported for the same compound with Escherichia coli DXR.lld:pubmed
pubmed-article:15454217pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:languageenglld:pubmed
pubmed-article:15454217pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:citationSubsetIMlld:pubmed
pubmed-article:15454217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15454217pubmed:statusMEDLINElld:pubmed
pubmed-article:15454217pubmed:monthNovlld:pubmed
pubmed-article:15454217pubmed:issn0960-894Xlld:pubmed
pubmed-article:15454217pubmed:authorpubmed-author:ProteauPhilip...lld:pubmed
pubmed-article:15454217pubmed:authorpubmed-author:PhaosiriChano...lld:pubmed
pubmed-article:15454217pubmed:issnTypePrintlld:pubmed
pubmed-article:15454217pubmed:day1lld:pubmed
pubmed-article:15454217pubmed:volume14lld:pubmed
pubmed-article:15454217pubmed:ownerNLMlld:pubmed
pubmed-article:15454217pubmed:authorsCompleteYlld:pubmed
pubmed-article:15454217pubmed:pagination5309-12lld:pubmed
pubmed-article:15454217pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15454217pubmed:meshHeadingpubmed-meshheading:15454217...lld:pubmed
pubmed-article:15454217pubmed:meshHeadingpubmed-meshheading:15454217...lld:pubmed
pubmed-article:15454217pubmed:meshHeadingpubmed-meshheading:15454217...lld:pubmed
pubmed-article:15454217pubmed:meshHeadingpubmed-meshheading:15454217...lld:pubmed
pubmed-article:15454217pubmed:meshHeadingpubmed-meshheading:15454217...lld:pubmed
pubmed-article:15454217pubmed:meshHeadingpubmed-meshheading:15454217...lld:pubmed
pubmed-article:15454217pubmed:meshHeadingpubmed-meshheading:15454217...lld:pubmed
pubmed-article:15454217pubmed:meshHeadingpubmed-meshheading:15454217...lld:pubmed
pubmed-article:15454217pubmed:meshHeadingpubmed-meshheading:15454217...lld:pubmed
pubmed-article:15454217pubmed:year2004lld:pubmed
pubmed-article:15454217pubmed:articleTitleSubstrate analogs for the investigation of deoxyxylulose 5-phosphate reductoisomerase inhibition: synthesis and evaluation.lld:pubmed
pubmed-article:15454217pubmed:affiliationCollege of Pharmacy, Pharmacy Building. Rm. 203, Oregon State University, Corvallis, OR 97331-3507, USA.lld:pubmed
pubmed-article:15454217pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15454217pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15454217pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:15454217lld:chembl
entrez-gene:945019entrezgene:pubmedpubmed-article:15454217lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15454217lld:pubmed